Skip to main content

Belgium

07
Feb 2024

Updated Convention for reimbursement of kidney dialysis in Belgium

In Belgium, kidney dialysis is reimbursed under a specific agreement (Convention) between the National Institute for Health and Disability Insurance (INAMI-RIZIV) and chronic kidney failure centers starting in 2018. The current update of the Convention came into force on January 1, 2024, and is valid until December 31, 2026. Four new Pseudo-nomenclature codes for informing and training patients were added.
31
Jan 2024

2024 APR-DRG system released in Belgium

On January 15, 2024, the National Institute for Health and Disability Insurance (INAMI-RIZIV) released an updated DRG system for 2024. No significant changes were made aand no new APR-DRGs were added; thus. The reimbursement tariffs were increased by about 5%.
27
Nov 2023

Reduction of reimbursement for the clinical laboratory by 15% in Belgium

In November 2023, the Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) announced the budget reduction for reimbursement of clinical laboratory services by 15% from January 2024. INAMI-RIZIV considers this reimbursement still sufficient and will reallocate released funds to other projects in health care. The reduction will not impact molecular biological and genetic testing.
27
Jul 2023

Health apps reimbursement process updated in Belgium

In July 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) significantly updated the process to obtain reimbursement for health apps. More stakeholders, including the industry, can now submit an application to INAMI-RIZIV for temporary or permanent reimbursement. The new process will come into force on October 1, 2023.
24
Jul 2023

Extended reimbursement for next-generation sequencing (NGS) in Belgium

In late June 2023, the National Institute for Health and Disability Insurance (INAMI-RIZIV) decided to extend reimbursement for molecular biology tests by next-generation sequencing (NGS) for one year until June 30, 2024. NGS in oncology and hemato-oncology are temporarily reimbursed as a pilot under a specific agreement (Convention) with INAMI-RIZIV from 2019.
11
Jul 2023

New KCE report on the performance of the Belgian healthcare system

In June 2023, the Belgian Health Care Knowledge Center (KCE) published Health Services Research concerning the performance of the Belgian healthcare system. KCE regularly conducts such "check-ups" of the healthcare system in collaboration with Sciensano, the National Institute for Health and Disability Insurance (INAMI/RIZIV), and the FPS Public Health. The conceptual framework and the list of performance indicators were revised and updated.
07
Jul 2023

Regular update of the List of reimbursable devices and Nominative Lists in Belgium

On June 8, 2023, Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) published an updated List of reimbursable devices and Nominative lists of brands to come into force on July 1, 2023. Three new material codes concerning cardiovascular and spinal procedures were introduced. Several new branded devices were registered on the Nominative Lists connected to new and already existing material codes.